Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,587.68
(
-0.56%
)
US TECH 100
23,613.60
(
-0.77%
)
Dow Jones
45,880.32
(
-0.75%
)
Brent Oil
107.50
(
0.86%
)
Bitcoin
69,498.93
(
-2.45%
)
News Focus
News Focus
Post# of 257259
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122799
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 164591

Tuesday, 09/10/2013 1:41:16 PM

Tuesday, September 10, 2013 1:41:16 PM

Post# of 257259
ABBV/ENTA will probably not present partial results of the 6-trial global registration program at 2013 AASLD, according to today’s MS webcast; instead, they will likely present all 6 trials together at a later medical meeting. The last of these six trials to report data is expected to be PEARL-2, which is scheduled to complete in Mar 2014 (see #msg-90408583).

Results of some or all of the six individual phase-3 trials may be reported by press release.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now